Posted by Michael Wonder on 23 Apr 2026
Regeneron announces agreement with US Government to help lower drug costs for American patients and will provide innovative new gene therapy for free in the US
23 April 2026 - Regeneron Pharmaceuticals today announced an agreement with the US Government to help lower prices of several of its current and future life-changing medicines and offer an important new medicine for free in the US, ensuring American patients gain broader access to innovative treatments.
Regeneron leaders and co-founders Leonard Schleifer, M.D., Ph.D., and George Yancopoulos, M.D., Ph.D., joined President Donald J. Trump and members of his Administration at the White House to discuss the new agreement, through which Regeneron has addressed the four requests set forth in the President’s July 31st letter with existing and new programs.
